DocuSign misses by $0.03, beats on revs; guides OctQ revs above consensus; guides FY20 revs above consensus, raises full year billings guidance
Reports Q2 (Jul) earnings of $0.01 per share, excluding non-recurring items, $0.03 worse than the S&P Capital IQ Consensus of $0.04; revenues rose 41.0% year/year to $235.61 mln vs the $220.81 mln S&P Capital IQ Consensus and vs prior guidance of $218-222 mln.
- Co reports Q2 billings of $252.4 mln, well ahead of prior guidance of $215-225 mln.
- Co issues upside guidance for Q3 (Oct), sees Q3 revs of $237-241 mln vs. $231.9 mln S&P Capital IQ Consensus. Guides to Q3 billings of $260-270 mln.
- Co issues upside guidance for FY20, sees FY20 revs of $947-951 mln vs. $920.39 mln S&P Capital IQ Consensus.
- Increases full year billings guidance to $1.063-1.083 bln from $1.01-1.03 bln.
No comments:
Post a Comment